Preview Mode Links will not work in preview mode

Apr 19, 2021

Proceedings from part 3 of a 4-part webinar series. Featuring perspectives from Drs Robert Z Orlowski, S Vincent Rajkumar and Edward A Stadtmauer, including the following topics:

  • Introduction (0:00)
  • Up-front management of multiple myeloma (MM) (0:52)
  • Treatment options for relapsed/refractory (R/R) MM (19:21)
  • Efficacy and safety of chimeric antigen receptor T-cell therapy and bispecific antibodies in patients with R/R MM (31:42)
  • Other novel therapeutic strategies in the management of MM (46:42)

CME information and select publications